Inhibitors of human immunodeficiency virus replication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9855230
SERIAL NO

15507855

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIIV HEALTHCARE UK (NO 5) LIMITEDSTEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Belema, Makonen Wallingford, US 73 1671
Bender, John A Wallingford, US 66 917
Beno, Brett Wallingford, US 1 0
Gentles, Robert G Wallingford, US 36 567
Li, Guo Wallingford, US 48 410
Meanwell, Nicholas A Wallingford, US 189 2698
Pendri, Annapurna Wallingford, US 54 2240
Yang, Zhong Wallingford, US 44 342
Zhu, Shirong Wallingford, US 13 56

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00